Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 198

1.

Modulation of HIV-1 macrophage-tropism among R5 envelopes occurs before detection of neutralizing antibodies.

Richards KH, Aasa-Chapman MM, McKnight A, Clapham PR.

Retrovirology. 2010 May 27;7:48. doi: 10.1186/1742-4690-7-48.

2.

High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men.

Li H, Bar KJ, Wang S, Decker JM, Chen Y, Sun C, Salazar-Gonzalez JF, Salazar MG, Learn GH, Morgan CJ, Schumacher JE, Hraber P, Giorgi EE, Bhattacharya T, Korber BT, Perelson AS, Eron JJ, Cohen MS, Hicks CB, Haynes BF, Markowitz M, Keele BF, Hahn BH, Shaw GM.

PLoS Pathog. 2010 May 13;6(5):e1000890. doi: 10.1371/journal.ppat.1000890.

3.

CCR5 antagonists: host-targeted antiviral agents for the treatment of HIV infection, 4 years on.

Westby M, van der Ryst E.

Antivir Chem Chemother. 2010 Apr 14;20(5):179-92. doi: 10.3851/IMP1507. Review.

PMID:
20413825
4.

Wide variation in the multiplicity of HIV-1 infection among injection drug users.

Bar KJ, Li H, Chamberland A, Tremblay C, Routy JP, Grayson T, Sun C, Wang S, Learn GH, Morgan CJ, Schumacher JE, Haynes BF, Keele BF, Hahn BH, Shaw GM.

J Virol. 2010 Jun;84(12):6241-7. doi: 10.1128/JVI.00077-10. Epub 2010 Apr 7.

5.

Molecular Mechanisms of Neurodegenerative Diseases Induced by Human Retroviruses: A Review.

Irish BP, Khan ZK, Jain P, Nonnemacher MR, Pirrone V, Rahman S, Rajagopalan N, Suchitra JB, Mostoller K, Wigdahl B.

Am J Infect Dis. 2009 Jul 1;5(3):231-258.

6.

HIV-1 infects multipotent progenitor cells causing cell death and establishing latent cellular reservoirs.

Carter CC, Onafuwa-Nuga A, McNamara LA, Riddell J 4th, Bixby D, Savona MR, Collins KL.

Nat Med. 2010 Apr;16(4):446-51. doi: 10.1038/nm.2109. Epub 2010 Mar 7.

7.

Maraviroc in the treatment of HIV infection.

Ray N.

Drug Des Devel Ther. 2009 Feb 6;2:151-61.

8.

Phenotype variation in human immunodeficiency virus type 1 transmission and disease progression.

Cavarelli M, Scarlatti G.

Dis Markers. 2009;27(3):121-36. doi: 10.3233/DMA-2009-0656. Review.

9.

CNS inflammation and macrophage/microglial biology associated with HIV-1 infection.

Yadav A, Collman RG.

J Neuroimmune Pharmacol. 2009 Dec;4(4):430-47. doi: 10.1007/s11481-009-9174-2. Epub 2009 Sep 19. Review.

PMID:
19768553
10.

Extensive astrocyte infection is prominent in human immunodeficiency virus-associated dementia.

Churchill MJ, Wesselingh SL, Cowley D, Pardo CA, McArthur JC, Brew BJ, Gorry PR.

Ann Neurol. 2009 Aug;66(2):253-8. doi: 10.1002/ana.21697.

PMID:
19743454
11.

Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target.

Walker LM, Phogat SK, Chan-Hui PY, Wagner D, Phung P, Goss JL, Wrin T, Simek MD, Fling S, Mitcham JL, Lehrman JK, Priddy FH, Olsen OA, Frey SM, Hammond PW; Protocol G Principal Investigators, Kaminsky S, Zamb T, Moyle M, Koff WC, Poignard P, Burton DR.

Science. 2009 Oct 9;326(5950):285-9. doi: 10.1126/science.1178746. Epub 2009 Sep 3.

12.

Lack of in vivo compartmentalization among HIV-1 infected naïve and memory CD4+ T cell subsets.

Heeregrave EJ, Geels MJ, Brenchley JM, Baan E, Ambrozak DR, van der Sluis RM, Bennemeer R, Douek DC, Goudsmit J, Pollakis G, Koup RA, Paxton WA.

Virology. 2009 Oct 10;393(1):24-32. doi: 10.1016/j.virol.2009.07.011. Epub 2009 Aug 20.

13.

Mechanism of human immunodeficiency virus type 1 resistance to monoclonal antibody B12 that effectively targets the site of CD4 attachment.

Wu X, Zhou T, O'Dell S, Wyatt RT, Kwong PD, Mascola JR.

J Virol. 2009 Nov;83(21):10892-907. doi: 10.1128/JVI.01142-09. Epub 2009 Aug 19.

14.
15.

Virus entry via the alternative coreceptors CCR3 and FPRL1 differs by human immunodeficiency virus type 1 subtype.

Nedellec R, Coetzer M, Shimizu N, Hoshino H, Polonis VR, Morris L, Mårtensson UE, Binley J, Overbaugh J, Mosier DE.

J Virol. 2009 Sep;83(17):8353-63. doi: 10.1128/JVI.00780-09. Epub 2009 Jun 24.

16.

Heterosexual transmission of human immunodeficiency virus type 1 subtype C: Macrophage tropism, alternative coreceptor use, and the molecular anatomy of CCR5 utilization.

Isaacman-Beck J, Hermann EA, Yi Y, Ratcliffe SJ, Mulenga J, Allen S, Hunter E, Derdeyn CA, Collman RG.

J Virol. 2009 Aug;83(16):8208-20. doi: 10.1128/JVI.00296-09. Epub 2009 Jun 10.

17.

Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection.

Salazar-Gonzalez JF, Salazar MG, Keele BF, Learn GH, Giorgi EE, Li H, Decker JM, Wang S, Baalwa J, Kraus MH, Parrish NF, Shaw KS, Guffey MB, Bar KJ, Davis KL, Ochsenbauer-Jambor C, Kappes JC, Saag MS, Cohen MS, Mulenga J, Derdeyn CA, Allen S, Hunter E, Markowitz M, Hraber P, Perelson AS, Bhattacharya T, Haynes BF, Korber BT, Hahn BH, Shaw GM.

J Exp Med. 2009 Jun 8;206(6):1273-89. doi: 10.1084/jem.20090378. Epub 2009 Jun 1.

18.

HIV-1 in genital compartments: vexing viral reservoirs.

Craigo JK, Gupta P.

Curr Opin HIV AIDS. 2006 Mar;1(2):97-102. doi: 10.1097/01.COH.0000200507.27578.26.

PMID:
19372791
19.

Acute HIV infection: it takes more than guts.

Mattapallil JJ, Roederer M.

Curr Opin HIV AIDS. 2006 Jan;1(1):10-5. doi: 10.1097/01.COH.0000191896.70685.74.

PMID:
19372777
20.

How HIV changes its tropism: evolution and adaptation?

Mosier DE.

Curr Opin HIV AIDS. 2009 Mar;4(2):125-30. doi: 10.1097/COH.0b013e3283223d61. Review.

Supplemental Content

Support Center